Home LiteratureArticle Details
PMID: 11113859 Published · ppublish English Journal Article

Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer.

The Journal of pathology ·Vol. 192 ·No. 4 ·2000-12-00 ·Pages 433-9

Ohene-Abuakwa Y, Noda M, Perenyi M, Kobayashi N, Kashima K, Hattori T, Pignatelli M

Abstract

E-cadherin and its associated cytoplasmic proteins, alpha-, beta-, and gamma-catenins, play an essential role in the control of epithelial differentiation. We have previously shown that loss or down-regulation of E-cadherin/catenin correlates with poor survival in advanced gastric adenocarcinoma. The aim of this study was to assess the expression of E-cadherin and catenins in early gastric cancers (EGCs). Immunohistochemical staining for E-cadherin and alpha-, beta-, and gamma-catenins was performed on 41 paraffin-embedded gastrectomy specimens of EGC using an indirect immunoperoxidase technique. The pattern of expression and cellular localization of the E-cadherin/catenin complex in tumour cells were correlated with the macroscopic appearance of the tumour according to the Japanese Endoscopic Society classification. The tumours were classified as follows: three type I (protruding) and 38 type II (superficial), of which ten were type IIa (elevated), one was type IIb (flat), and 27 were type IIc (depressed). E-cadherin and alpha-, beta-, and gamma-catenins were expressed at the cell-cell junctions in normal mucosa. Forty out of 41 tumours showed abnormal expression (loss of membranous immunoreactivity and/or nuclear staining) of at least one component of the E-cadherin catenin complex. Loss of E-cadherin immunoreactivity was more frequently seen in type IIb (1/1, 100%) and type IIc (27/27, 100%) than in type I (1/3, 33%) and type IIa (1/10, 10%) (p<0.01). Abnormal expression of E-cadherin and alpha-catenin was more frequently seen in diffuse-type than in intestinal type tumours (p<0.05). Abnormal immunoreactivity of beta- and gamma-catenin, including nuclear localization, was observed in 34% and 7.3% of tumours, respectively, but there was no significant correlation with tumour type or endoscopic appearance. In conclusion, abnormal expression of the E-cadherin/catenin complex occurs in EGC and seems to correlate with macroscopic appearances.

MeSH Terms
Adenocarcinoma/metabolism,pathology Adult Aged Aged, 80 and over Biomarkers, Tumor/metabolism Cadherins/metabolism Cytoskeletal Proteins/metabolism Desmoplakins Gastric Mucosa/metabolism Humans Immunoenzyme Techniques Middle Aged Neoplasm Invasiveness Neoplasm Proteins/metabolism Stomach Neoplasms/metabolism,pathology Trans-Activators alpha Catenin beta Catenin gamma Catenin
Chemicals
Biomarkers, Tumor CTNNA1 protein, human CTNNB1 protein, human Cadherins Cytoskeletal Proteins Desmoplakins JUP protein, human Neoplasm Proteins Trans-Activators alpha Catenin beta Catenin gamma Catenin
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Ohene-Abuakwa Y
Division of Histopathology, Department of Pathology and Microbiology, University of Bristol, Bristol Royal Infirmary, Bristol, UK.
Noda M
Perenyi M
Kobayashi N
Kashima K
Hattori T
Pignatelli M
Article Info
Journal
The Journal of pathology
Abbr.
J Pathol
ISSN
0022-3417
Published
2000-12-00
Pages
433-9
Language
English
Region
England
NLM ID
0204634
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com